Fundraising FoxEleven Tx
2 known investors
Find your way into Eleven Tx
Sign up to find every way you can get introduced to Eleven Tx
- Your email: who you already know at Eleven Tx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eleven Tx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
Founders & leadership
Investors · 2
Entrée Capitallisted by Entrée CapitalTel Aviv · $150K – $15M
How we know: Entrée Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Eleven Tx do?
- Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
- Who founded Eleven Tx?
- Eleven Tx was founded by Adi Gilboa-Geffen, Shaul Ilan, Yaniv Erlich.
- Who are Eleven Tx's investors?
- Eleven Tx's investors include Entrée Capital, Kindred Capital.